BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iwasaki W, Kume M, Kudo K, Uchinami H, Kikuchi I, Nakagawa Y, Yoshioka M, Yamamoto Y. CHANGES IN THE FATTY ACID COMPOSITION OF THE LIVER WITH THE ADMINISTRATION OF N-3 POLYUNSATURATED FATTY ACIDS AND THE EFFECTS ON WARM ISCHEMIA/REPERFUSION INJURY IN THE RAT LIVER. Shock 2010;33:306-14. [DOI: 10.1097/shk.0b013e3181b2ffd2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zúñiga J, Cancino M, Medina F, Varela P, Vargas R, Tapia G, Videla LA, Fernández V. N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. PLoS One. 2011;6:e28502. [PMID: 22174823 DOI: 10.1371/journal.pone.0028502] [Cited by in Crossref: 118] [Cited by in F6Publishing: 109] [Article Influence: 10.7] [Reference Citation Analysis]
2 Clemens MG. What's new in Shock, March 2010? Shock 2010;33:227-8. [PMID: 20160608 DOI: 10.1097/SHK.0b013e3181ce984a] [Reference Citation Analysis]
3 Baker MA, Nandivada P, Mitchell PD, Fell GL, Pan A, Cho BS, De La Flor DJ, Anez-Bustillos L, Dao DT, Nosé V, Puder M. Omega-3 fatty acids are protective in hepatic ischemia reperfusion injury in the absence of GPR120 signaling. J Pediatr Surg 2019;54:2392-7. [PMID: 31036368 DOI: 10.1016/j.jpedsurg.2019.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Coelho AM, Machado MC, Takahashi HK, Sampietre SN, Stefano JT, Leite AZ, Curi R, D'Albuquerque LA. Ischemic preconditioning-like effect of polyunsaturated fatty acid-rich diet on hepatic ischemia/reperfusion injury. J Gastrointest Surg 2011;15:1679-88. [PMID: 21826546 DOI: 10.1007/s11605-011-1648-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
5 Ahmed AA, Balogun KA, Bykova NV, Cheema SK. Novel regulatory roles of omega-3 fatty acids in metabolic pathways: a proteomics approach. Nutr Metab (Lond) 2014;11:6. [PMID: 24438320 DOI: 10.1186/1743-7075-11-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
6 Fernández V, Tapia G, Videla LA. Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron. World J Hepatol 2012; 4(4): 119-128 [PMID: 22567184 DOI: 10.4254/wjh.v4.i4.119] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
7 Yan XP, Qiu YD. Injury of the hepatic barrier and intestinal barrier in patients with small-for-size graft syndrome after partial liver transplantation: mechanisms and protective measures. Shijie Huaren Xiaohua Zazhi 2012; 20(1): 47-52 [DOI: 10.11569/wcjd.v20.i1.47] [Reference Citation Analysis]
8 Zhu XH, Wu YF, Qiu YD, Jiang CP, Ding YT. Liver-protecting effects of omega-3 fish oil lipid emulsion in liver transplantation. World J Gastroenterol 2012; 18(42): 6141-6147 [PMID: 23155344 DOI: 10.3748/wjg.v18.i42.6141] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]